Squadron Capital Management LLC 13F Portfolio
| Entity | Category | QoQ AUM Change | AUM (13F) | # of Holdings | Performance Rank | Equities Trend |
|---|---|---|---|---|---|---|
SC Squadron Capital Management LLC | Institutional Filer | ▲ 7.59% | $241.1M | 28 |
Current Portfolio Holdings
Showing all 28 reported positions by value
| # | Stock | Company Name | Sector | Shares Held | Market Value | % of Portfolio |
|---|---|---|---|---|---|---|
| 1 | RLMD | Relmada Therapeutics, Inc. | Healthcare | 8.5M | $59.0M | 24.46% |
| 2 | COGT | Cogent Biosciences, Inc. | Healthcare | 787K | $30.3M | 12.57% |
| 3 | KALV | KalVista Pharmaceuticals, Inc. | Healthcare | 1.3M | $26.2M | 10.85% |
| 4 | KOD | Kodiak Sciences Inc. | Healthcare | 380K | $14.5M | 6.01% |
| 5 | ABVX | Abivax S.A. | Healthcare | 130K | $14.5M | 6.00% |
| 6 | EWTX | Edgewise Therapeutics, Inc. | Healthcare | 350K | $11.0M | 4.57% |
| 7 | NKTR | Nektar Therapeutics | Healthcare | 125K | $9.0M | 3.73% |
| 8 | ANL | Adlai Nortye Ltd. | Healthcare | 1.3M | $8.8M | 3.63% |
| 9 | MAZE | Maze Therapeutics, Inc. | Healthcare | 258K | $7.7M | 3.19% |
| 10 | SCYX | SCYNEXIS, Inc. | Healthcare | 7.6M | $7.0M | 2.89% |
| 11 | CCCC | C4 Therapeutics, Inc. | Healthcare | 2.3M | $5.9M | 2.45% |
| 12 | IKT | Inhibikase Therapeutics, Inc. | Healthcare | 3.5M | $5.9M | 2.44% |
| 13 | PALI | Palisade Bio, Inc. | Healthcare | 3.0M | $5.3M | 2.18% |
| 14 | EPRX | Eupraxia Pharmaceuticals Inc. | Healthcare | 680K | $4.9M | 2.04% |
| 15 | GHRS | GH Research PLC | Healthcare | 325K | $4.6M | 1.90% |
Showing 1 to 15 of 28 holdings